NCT00232648View on ClinicalTrials.gov

Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Asthma
Interventions
DRUG

Pulmicort (budesonide) Respules

Trial Locations (9)

Unknown

Fukuoka

Isehara

Tsu

Kurashiki

Hioshima

Kanagawa

Matsuyama

Obhu-city

Tokyo

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY